NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons
Sponsored by NOWDiagnostics, Inc.
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- PCR positives: persons who were symptomatic for COVID-19 and have tested positive for COVID-19 with an EUA or FDA cleared PCR test; 7+ days post positive PCR test
- PCR negatives: persons who have never had COVID-19 and who have tested negative for COVID-19 with an EUA or FDA cleared PCR test; within 0-6 days post negative PCR test
- persons 2+ years old Vaccination Cohort>
- persons 7- 60 days post second dose of EUA COVID-19 vaccine
- persons 18+ years old
Exclusion Criteria
- PCR positives: persons with a COVID-19 positive test result >45 days old
- PCR negatives: persons with any prior COVID-19 positive result
- persons who have received COVID-19 vaccine
- persons <2 years old Vaccination Cohort>
- persons symptomatic or previously infected with COVID-19 prior to vaccination
- persons <18 years old